摘要
目的:拟探讨α-烯醇化酶(α-enolase,ENO1)在卵巢癌中的表达及其预后意义。方法:收集Oncomine数据库中关于ENO1的信息,并对目前数据库中资料进行二次分析,对其在卵巢癌中的作用进行荟萃分析,同时利用Kaplan-Meier Plotter进行卵巢癌患者生存分析。结果:Oncomine数据库中共有14项研究涉及ENO1在卵巢癌组织和正常组织中的表达,共包括1 001个样本。与对照组相比,ENO1在卵巢癌组织中高表达(P<0.05)。高表达ENO1的卵巢癌患者总体生存率较高,而低表达ENO1的卵巢癌患者预后较差(P<0.05)。进一步亚组分析发现,ENO1表达水平对浆液性卵巢癌患者预后有显著影响,而在子宫内膜样卵巢癌患者中,其表达水平对预后无显著影响(P<0.05)。结论:通过对Oncomine基因芯片数据库中肿瘤相关基因信息的深入挖掘,发现ENO1在卵巢癌中高表达,且与卵巢癌的预后有关,可作为肿瘤预后标志物及替代药物治疗的新靶点。
Objective:Ovarian cancer is one of the leading causes of death in women,because of late diagnosis,recurrence and resistance to chemotherapy.Therefore,it's needed to design a novel sensitive and specific maker to diagnose and treat patients of ovarian cancer.However,this study intends to explore the expression and prognostic value of ENO1 in ovarian cancer.Methods:ENO1 data were collected from Oncomine database,and then were performed subgroup analysis and systematic analysis.Meanwhile,the prognostic significance of ENO1 was analyzed by an online survival analysis tool"Kaplan-Meier Plotter"(KM plotter)database.Results:In Oncomine database,a total of 14 studies were involved ENO1 in ovarian cancer tissues and normal tissues,including a total of 1001 samples.Comparing with normal tissues,ENO1 expression is higher(P<0.05).Moreover,the overall survival of ENO1 high expression in ovarian cancer is closely related with high survival(P<0.05).Further study indicated that ENO1 expression showed negative relation to the prognosis of serous ovarian cancer patients while ENO1 expression showed no effects on the prognosis of endometrioid ovarian cancer patients.Conclusion:Through exploration of tumor gene information in Oncomine database,ENO1 was found highly expressed in ovarian cancer and related to the prognosis of ovarian cancer,which might be a new marker for ovarian cancer prognosis and alternative drug therapy.
作者
张涛红
熊莉莉
王小伟
王伟红
刘英
安瑞芳
ZHANG Tao-hong;XIONG Li-li;WANG Xiao-wei;WANG Wei-hong;LIU Ying;AN Rui-fang(Department of Obstetrics and Gynecology,the First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Shaanxi 710061,China)
出处
《海南医学院学报》
CAS
2019年第18期1405-1409,共5页
Journal of Hainan Medical University
基金
陕西省科技统筹创新计划(2016KTCL03-06)~~
